20 Results for "

MKK7

" in MedChemExpress (MCE) Product Catalog:
Products (20)

20 Results for "MKK7" in MCE Product Catalog:

13
13 Publications Verification
Cat. No.: HY-13866
CAS No.: 138489-18-6
Purity:  99.57%
Synonyms: Ro 31-8220 methanesulfonate; Bisindolylmaleimide IX mesylate
Target:  

PKC JNK

Ro 31-8220 mesylate is a potent PKC inhibitor, with IC50s of 5, 24, 14, 27, 24 and 23 nM for PKCα, PKCβI, PKCβII, PKCγ, PKCε and rat brain PKC, respectively. Ro 31-8220 also significantly inhibits MAPKAP-K1b, MSK1, S6K1 and GSK3β (IC50s, 3, 8, 15, and 38 nM, respectively), with no effect on MKK3, MKK4, MKK6 and MKK7. Ro 31-8220 mesylate can also inhibit the expression of MKP-1, induce the expression of c-Jun, and activate JNK, and these effects possess pharmacological properties independent of PKC .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-152185
CAS No.: 2513289-74-0
Purity:  99.86%
Target:  

p38 MAPK

Research Areas:  

Cancer

BSJ-04-122 is a covalent MKK4/7 dual inhibitor. BSJ-04-122 inhibits MKK4 and MKK7 with IC50 values of 4 nM and 181 nM, respectively. BSJ-04-122 can be used for the research of cancer .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-100538
CAS No.: 1809784-29-9
Purity:  99.56%
Target:  

DNA/RNA Synthesis JAK

Research Areas:  

Cancer

DTP3 TFA is a potent and selective GADD45β/MKK7 inhibitor. DTP3 TFA targets an essential, cancer-selective cell-survival module downstream of the NF-κB pathway .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-100538A
CAS No.: 2759216-46-9
Purity:  98.00%
Target:  

DNA/RNA Synthesis JNK

Research Areas:  

Cancer

DTP3 TFA is a potent and selective GADD45β/MKK7 (growth arrest and DNA-damage-inducible β/mitogen-activated protein kinase kinase 7) inhibitor. DTP3 TFA targets an essential, cancer-selective cell-survival module downstream of the NF-κB pathway .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N7394A
CAS No.: 84709-25-1
Synonyms: D-Epigalbacin
(-)-Zuonin A (D-Epigalbacin), a naturally occurring lignin, is a potent, selective JNKs inhibitor, with IC50s of 1.7 μM, 2.9 μM and 1.74 μM for JNK1, JNK2 and JNK3, respectively .
loading...
    loading...
Cat. No.: HY-152860
CAS No.: 2369583-33-3
Purity:  99.94%
Synonyms: HRX-0215
Research Areas:  

Cancer

Darizmetinib (HRX-0215) is an orally active, potent and selective inhibitor of mitogen-activated protein kinase kinase 4 (MKK4). Darizmetinib leads to enhancement of the MKK7 and JNK1 signaling pathways, thereby activating the transcription factors ATF2 and ELK1, promoting cell proliferation and liver regeneration. Darizmetinib is promising for research of preventing liver failure after extensive oncological liver resections or transplantation of small liver grafts .
loading...
    loading...
Cat. No.: HY-122872
CAS No.: 2283355-59-7
Purity:  97.69%
Target:  

p38 MAPK

Research Areas:  

Cancer

MKK7-COV-9 is a potent and selective covalent inhibitor of MKK7 and targets a specific protein-protein interaction of MKK7. MKK7-COV-9 blocks primary B cell activation in response to LPS with an EC50 of 4.98 μM .
loading...
    loading...
Cat. No.: HY-13866A
CAS No.: 125314-64-9
Synonyms: Bisindolylmaleimide IX
Target:  

PKC JNK

Ro 31-8220 is a potent PKC inhibitor, with IC50s of 5, 24, 14, 27, 24 and 23 nM for PKCα, PKCβI, PKCβII, PKCγ, PKCε and rat brain PKC, respectively. Ro 31-8220 also significantly inhibits MAPKAP-K1b, MSK1, S6K1 and GSK3β (IC50s, 3, 8, 15, and 38 nM, respectively), with no effect on MKK3, MKK4, MKK6 and MKK7. Ro 31-8220 can also inhibit the expression of MKP-1, induce the expression of c-Jun, and activate JNK, and these effects possess pharmacological properties independent of PKC .
loading...
    loading...
Cat. No.: HY-N4006
CAS No.: 129280-34-8
Isoangustone A is an anticancer and anti-inflammatory agent. Isoangustone A induces cancer cells apoptosis and autophagic cell death .
loading...
    loading...
Cat. No.: HY-179044
CAS No.: 3100092-62-1
Research Areas:  

Cancer

MKK7-JNK activator 1 (Compound 10) is a MKK7-JNK pathway activator. MKK7-JNK activator 1 effectively inhibits the proliferation and migration of MDA-MB-468 cells, induces G2/M phase arrest and caspase -dependent apoptosis (independent of ROS production). MKK7-JNK activator 1 significantly increases the levels of p-MKK7 and p-JNK, but does not affect p-ERK or p-p38. MKK7-JNK activator 1 can be used for the study of triple-negative breast cancer (TNBC) .
loading...
    loading...
Cat. No.: HY-14411
CAS No.: 1262406-02-9
Target:  

JNK

Research Areas:  

Cancer

JNK-1-IN-1 is a JNK-1 inhibitor. JNK-1-IN-1 also inhibits MKK7 with an IC50 of 7.8μM. JNK-1-IN-1 bind to MKK7cp and acts as an inhibitor of JNK-1 .
loading...
    loading...
Cat. No.: HY-176228
Target:  

p38 MAPK

Research Areas:  

Others

WEIZ-WX-04-008 (Compound 1) is a covalent Lysine-targeting MKK7 inhibitor with IC50 of 738 nM .
loading...
    loading...
Cat. No.: HY-181812
JNK2/MKK7 PPI-IN-1 is an orally active JNK2 inhibitor with an IC50 of 0.99 μM and a Kd of 81.6 μM. JNK2/MKK7 PPI-IN-1 inhibits JNK2 kinase activity, disrupts JNK2-MKK7 protein-protein interaction, and reduces c-Jun phosphorylation. JNK2/MKK7 PPI-IN-1 inhibits LPS-induced overexpression of inflammatory cytokines IL-6 and TNF-α. JNK2/MKK7 PPI-IN-1 can be used for the research of acute lung injury .
loading...
    loading...
Cat. No.: HY-N11723
CAS No.: 476-46-0
Synonyms: Katenarin
Catenarin, an anthraquinone compound, inhibits CCR5- and CXCR4-mediated chemotaxis. Catenarin reduces the phosphorylation of mitogen-activated protein kinases (p38 and JNK) and their upstream kinases (MKK6 and MKK7), and calcium mobilization. Catenarin shows anti-inflammatory effect and suppresses leukocyte migration in the diabetes. Catenarin exhibits significant inhibitory effects against Gram-positive bacteria. Catenarin prevents type 1 diabetes (T1D) in nonobese diabetic mice [1][2].
loading...
    loading...
Cat. No.: HY-100538R
CAS No.: 1809784-29-9
Research Areas:  

Cancer

DTP3 (Standard) is the analytical standard of DTP3 (HY-100538). This product is intended for research and analytical applications. DTP3 TFA is a potent and selective GADD45β/MKK7 inhibitor. DTP3 TFA targets an essential, cancer-selective cell-survival module downstream of the NF-κB pathway .
loading...
    loading...
Cat. No.: HY-RS08045
Research Areas:  

Others

MAP2K7 Human Pre-designed siRNA Set A contains three designed siRNAs for MAP2K7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-13866R
CAS No.: 138489-18-6
Synonyms: Ro 31-8220 methanesulfonate (Standard); Bisindolylmaleimide IX mesylate (Standard)
Ro 31-8220 mesylate (Standard) is the analytical standard of Ro 31-8220 mesylate (HY-13866). This product is intended for research and analytical applications. Ro 31-8220 mesylate is a potent PKC inhibitor, with IC50s of 5, 24, 14, 27, 24 and 23 nM for PKCα, PKCβI, PKCβII, PKCγ, PKCε and rat brain PKC, respectively. Ro 31-8220 also significantly inhibits MAPKAP-K1b, MSK1, S6K1 and GSK3β (IC50s, 3, 8, 15, and 38 nM, respectively), with no effect on MKK3, MKK4, MKK6 and MKK7. Ro 31-8220 mesylate can also inhibit the expression of MKP-1, induce the expression of c-Jun, and activate JNK, and these effects possess pharmacological properties independent of PKC .
loading...
    loading...
Cat. No.: HY-P82902
Synonyms: MAP2K7; JNKK2; MEK7; MKK7; PRKMK7; SKK4; Dual specificity mitogen-activated protein kinase kinase 7; MAP kinase kinase 7; MAPKK 7; JNK-activating kinase 2; MAPK/ERK kinase 7; MEK 7; Stress-activated protein kinase kinase 4; SAPK kinase 4; S

Host:  

Rabbit

Application:  

WB, IHC-P, ICC/IF, IP, FC

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-RS26286
Research Areas:  

Others

Map2k7 Rat Pre-designed siRNA Set A contains three designed siRNAs for Map2k7 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS19790
Research Areas:  

Others

Map2k7 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Map2k7 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
  • 1